ClinicalTrials.Veeva

Menu

Transition From Donor Milk: a Feasibility Study

Augusta University logo

Augusta University

Status

Enrolling

Conditions

Nutrition, Healthy
Preterm Birth

Treatments

Dietary Supplement: Preterm Infant Formula

Study type

Interventional

Funder types

Other

Identifiers

NCT06514014
2193903

Details and patient eligibility

About

Preterm and very low birth weight (VLBW, < 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.

Enrollment

20 estimated patients

Sex

All

Ages

28+ days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Greater than 1,250 grams
  2. At least 28 days of life
  3. Diet consisting of donor human milk with/without mother's own milk

Exclusion criteria

  1. Birth weight below the 5th percentile
  2. History of necrotizing enterocolitis, spontaneous intestinal perforation, or other gastrointestinal disorder
  3. Congenital anomalies
  4. Care team discretion

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Donor Milk
No Intervention group
Preterm Infant Formula
Active Comparator group
Treatment:
Dietary Supplement: Preterm Infant Formula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems